Knowledge, attitudes, and practices of seasonal influenza vaccination in postpartum women, Honduras.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2021
2021
Historique:
received:
08
07
2020
accepted:
16
01
2021
entrez:
11
2
2021
pubmed:
12
2
2021
medline:
28
7
2021
Statut:
epublish
Résumé
Influenza during pregnancy may cause serious neonatal outcomes including stillbirth, fetal distress, preterm birth, congenital abnormalities, and stunted growth. Pregnant women are the highest priority group for seasonal influenza vaccination, but low coverage has been repeatedly reported in this population. Understanding reasons for and for not receiving the seasonal influenza vaccine is needed to design communication strategies to increase vaccination coverage. This study aimed to describe knowledge, attitudes, and practices (KAP) of seasonal influenza vaccination among women giving birth in public maternity hospitals in Honduras. From August 20-October 8, 2018, we conducted a cross-sectional KAP survey regarding seasonal influenza vaccinations to a sample of postpartum women who gave birth in maternity hospitals and clinics from the Ministry of Health of Honduras and Honduran Social Security Institute. We reported frequency distributions for demographics, KAP of influenza vaccine, and vaccination coverage. We used logistic regression to analyze unadjusted and adjusted associations between sociodemographic characteristics and influenza vaccination. We surveyed 842 postpartum women in 17 healthcare facilities. Of 534 postpartum women with term pregnancy and verified vaccinations, 417 (78.1%; 95% CI: 74.6-81.6%) were vaccinated for influenza. Factors associated with verified influenza vaccination included receipt of vaccination recommendations by a healthcare worker during prenatal check-ups (aOR: 16.46; 95% CI: 9.73-27.85), concurrent chronic disease (aOR: 5.00; 95% CI: 1.25-20.07), and influenza vaccination of other children in the household (aOR: 2.28; 95% CI: 1.19-4.39). The most cited reasons for vaccination were perceived benefits for both mother and infant and easy access. Reasons for non-vaccination were: vaccine was not offered and fear of side effects, harm to the infant, and needles or pain caused by injection. Influenza vaccination was well received among postpartum women in Honduras. Increasing clinician recommendations for vaccination and assuring the vaccine is readily available to women during prenatal visits may increase vaccination rates.
Sections du résumé
BACKGROUND
Influenza during pregnancy may cause serious neonatal outcomes including stillbirth, fetal distress, preterm birth, congenital abnormalities, and stunted growth. Pregnant women are the highest priority group for seasonal influenza vaccination, but low coverage has been repeatedly reported in this population. Understanding reasons for and for not receiving the seasonal influenza vaccine is needed to design communication strategies to increase vaccination coverage. This study aimed to describe knowledge, attitudes, and practices (KAP) of seasonal influenza vaccination among women giving birth in public maternity hospitals in Honduras.
METHODS
From August 20-October 8, 2018, we conducted a cross-sectional KAP survey regarding seasonal influenza vaccinations to a sample of postpartum women who gave birth in maternity hospitals and clinics from the Ministry of Health of Honduras and Honduran Social Security Institute. We reported frequency distributions for demographics, KAP of influenza vaccine, and vaccination coverage. We used logistic regression to analyze unadjusted and adjusted associations between sociodemographic characteristics and influenza vaccination.
RESULTS
We surveyed 842 postpartum women in 17 healthcare facilities. Of 534 postpartum women with term pregnancy and verified vaccinations, 417 (78.1%; 95% CI: 74.6-81.6%) were vaccinated for influenza. Factors associated with verified influenza vaccination included receipt of vaccination recommendations by a healthcare worker during prenatal check-ups (aOR: 16.46; 95% CI: 9.73-27.85), concurrent chronic disease (aOR: 5.00; 95% CI: 1.25-20.07), and influenza vaccination of other children in the household (aOR: 2.28; 95% CI: 1.19-4.39). The most cited reasons for vaccination were perceived benefits for both mother and infant and easy access. Reasons for non-vaccination were: vaccine was not offered and fear of side effects, harm to the infant, and needles or pain caused by injection.
CONCLUSION
Influenza vaccination was well received among postpartum women in Honduras. Increasing clinician recommendations for vaccination and assuring the vaccine is readily available to women during prenatal visits may increase vaccination rates.
Identifiants
pubmed: 33571256
doi: 10.1371/journal.pone.0246385
pii: PONE-D-20-21129
pmc: PMC7877664
doi:
Substances chimiques
Influenza Vaccines
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0246385Subventions
Organisme : FIC NIH HHS
ID : D43 TW009343
Pays : United States
Organisme : ACL HHS
ID : U01GH001003
Pays : United States
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
PLoS One. 2020 Jul 31;15(7):e0236793
pubmed: 32735607
Wkly Epidemiol Rec. 2012 Nov 23;87(47):461-76
pubmed: 23210147
Vaccine. 2014 Jul 16;32(33):4131-9
pubmed: 24928791
Acta Obstet Gynecol Scand. 2015 Aug;94(8):797-819
pubmed: 26012384
Emerg Infect Dis. 2015 Jul;21(7):1209-12
pubmed: 26079140
BMC Public Health. 2015 Jul 07;15:618
pubmed: 26148480
BJOG. 2017 Jan;124(1):48-59
pubmed: 27264387
J Pediatr. 2000 Dec;137(6):856-64
pubmed: 11113844
Lancet Respir Med. 2019 Jan;7(1):69-89
pubmed: 30553848
Vaccine. 2012 Aug 17;30(38):5661-5
pubmed: 22781306
Hum Vaccin Immunother. 2016 Aug 2;12(8):2206-2214
pubmed: 27196006
Vaccine. 2013 Oct 25;31(45):5281-8
pubmed: 24016814
Saudi Pharm J. 2017 Jan;25(1):76-82
pubmed: 28223865
J Matern Fetal Neonatal Med. 2011 Mar;24(3):402-6
pubmed: 20593974
Eur J Obstet Gynecol Reprod Biol. 2020 Apr;247:10-15
pubmed: 32044622
Expert Rev Vaccines. 2016 Aug;15(8):1055-62
pubmed: 27212228
Obstet Gynecol. 2010 May;115(5):919-923
pubmed: 20410763
MMWR Morb Mortal Wkly Rep. 2015 Aug 7;64(30):818-25
pubmed: 26247435
Pediatrics. 2014 Aug;134(2):e620-38
pubmed: 25070304
Vaccine. 2016 Feb 17;34(8):1086-90
pubmed: 26782740
Prev Med. 2012 Jul;55(1):72-7
pubmed: 22414740
J Matern Fetal Neonatal Med. 2012 Sep;25(9):1800-9
pubmed: 22339083
Influenza Other Respir Viruses. 2019 Mar;13(2):201-207
pubmed: 30099856
Vaccine. 2014 Aug 6;32(36):4602-13
pubmed: 24996123
Am J Prev Med. 2016 Apr;50(4):480-488
pubmed: 26526159
Med J Aust. 2013 Apr 15;198(7):373-5
pubmed: 23581957
J Obstet Gynaecol Can. 2009 Feb;31(2):120-5
pubmed: 19327210
CMAJ. 2007 Feb 13;176(4):463-8
pubmed: 17296958
Obstet Gynecol. 2006 Jun;107(6):1315-22
pubmed: 16738158
J Gen Intern Med. 2002 Sep;17(9):670-6
pubmed: 12220362
Pediatrics. 2016 Jun;137(6):
pubmed: 27244843